| #34 |
Sherwin D. Burrowes |
Rca |
1 |
| #34 |
Pratik Devasthale |
Bristol-Myers Squibb |
1 |
| #34 |
Patrick W. Blosser |
Engelhard |
1 |
| #34 |
Ravi K. Erukulla |
The Liposome Company |
1 |
| #34 |
Michelle Renee Corley |
Mcneil-Ppc |
1 |
| #34 |
Jerome J. Kukor |
Rutgers, The State University Of New Jersey |
1 |
| #34 |
Margaret A. Cascieri |
Merck |
1 |
| #34 |
Muyu Guo |
Diva Systems |
1 |
| #34 |
Todd Kassabian |
— |
1 |
| #34 |
Pamela R. Stergios |
R.P. Scherer Technologies |
1 |
| #34 |
Prakash Naik-Satam |
Johnson & Johnson |
1 |
| #34 |
Dake Tian |
Synaptic Pharmaceutical |
1 |
| #34 |
Karin Bickford |
Procedyne |
1 |
| #34 |
Vu Hien Nguyen |
Johnson & Johnson |
1 |
| #34 |
Terry S. Dugan |
Bristol-Myers Squibb |
1 |
| #34 |
Lawrence W. Dillard |
Cold Spring Harbor Laboratory |
1 |
| #34 |
George F. Renda |
Princeton Scientific Instruments |
1 |
| #34 |
Stuart J. Golin |
Intel |
1 |
| #34 |
William Karsh |
Amersham Biosciences |
1 |
| #34 |
Raymond J. Menna |
Rca |
1 |
| #34 |
Slobodan Nedic |
— |
1 |
| #34 |
Leo M. F. Chirovsky |
AT&T |
1 |
| #34 |
Toomas Mitt |
Bristol-Myers Squibb |
1 |
| #34 |
Dennis R. Anderson |
Engelhard |
1 |
| #34 |
Lap-Keung Lee |
Headwaters Heavy Oil |
1 |
| #34 |
Philip M. Sher |
Bristol-Myers Squibb |
1 |
| #34 |
David R. Magnin |
Bristol-Myers Squibb |
1 |
| #34 |
Chongqing Sun |
Bristol-Myers Squibb |
1 |
| #34 |
Steven Edward Lenicek |
Pfizer |
1 |
| #34 |
Remi Depommier |
Siemens Corporate Research |
1 |